News
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.
WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
The Novavax Covid-19 vaccine, which uses more traditional protein-based technology than the mRNA vaccines from ...
The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...
The U.S. FDA approved Novavax's COVID-19 vaccine with conditions, allowing use for people 65 and older and those 12-64 with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results